Hikari Power LTD Novo Nordisk A S Transaction History

Hikari Power LTD

$1.16 Billion
Q4 2024

A detailed history of Hikari Power LTD transactions in Novo Nordisk A S stock. As of the latest transaction made, Hikari Power LTD holds 130,300 shares of NVO stock, worth $9.89 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares

130,300

Previous 130,300 -0.0%

Holding current value

$9.89 Million

Previous $15.5 Million 27.76%

% of portfolio

0.97%

Previous 1.29%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$102.11 - $135.92 $1.61 Million - $2.14 Million	-15,750 Reduced 10.78%	130,300 $16.7 Million
Q4 2023 Jan 30, 2024	SELL	$87.78 - $105.45 $1.96 Million - $2.36 Million	-22,350 Reduced 13.27%	146,050 $15.1 Million
Q3 2023 Oct 25, 2023	BUY	$90.94 - $199.54 $6.68 Million - $14.7 Million	73,500 Added 77.45%	168,400 $15.3 Million
Q2 2023 Jul 25, 2023	SELL	$155.98 - $172.65 $3.43 Million - $3.8 Million	-22,000 Reduced 18.82%	94,900 $15.4 Million
Q4 2019 Feb 04, 2020	SELL	$49.86 - $58.26 $4.78 Million - $5.59 Million	-95,890 Reduced 45.06%	116,900 $6.77 Million
Q2 2019 Aug 08, 2019	SELL	$46.79 - $52.47 $1.66 Million - $1.86 Million	-35,500 Reduced 14.3%	212,790 $10.9 Million
Q1 2019 Apr 26, 2019	SELL	$46.36 - $52.63 $4.21 Million - $4.78 Million	-90,750 Reduced 26.77%	248,290 $13 Million
Q2 2018 Aug 02, 2018	SELL	$44.29 - $50.42 $3.75 Million - $4.27 Million	-84,760 Reduced 20.0%	339,040 $15.6 Million
Q2 2017 Aug 09, 2017	BUY	N/A	423,800	423,800 $18.2 Million

Others Institutions Holding NVO

# of Institutions

1,885

Shares Held

336M

Call Options Held

11.9M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $171B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hikari Power LTD, based on Form 13F filings with the SEC.

News

Stay updated on Hikari Power LTD with notifications on news.

Account